retatrutide triple agonist glp-1 gip glucagon phase 3 2025 Dual and Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data | Current Obesity Reports The most intensive medical obesity
Description
GLP-1 drugs may help reduce liver fat and inflammation, potentially slowing disease progression
Appetite suppression vs weight loss vs blood sugar: three different timelines One of the biggest sources of confusion is that GLP-1 medications produce multiple effects, and each one operates on its own timeline
GLP-1 receptor agonists vs
Nauck et al., 2020)
Make sure your insurance will approve the medication if your doctor prescribes a GLP-1 agonist
Building and rebalancing the gut microbiome is a process, not an overnight event
